News & Updates

For adults with early type 2 diabetes (T2D) not adequately controlled by diet and exercise alone, treatment with the investigational small-molecule, nonpeptide glucagon-like peptide-1 (GLP-1) receptor agonist orforglipron yields significant reductions in glycated haemoglobin levels, according to data from the phase III ACHIEVE-1 trial.

Daily intake of rice bran extract supplements (RBS) appears effective in reducing depressive symptoms in adults with mild-to-moderate symptom severity, reports a study, noting improvements reaching clinically relevant thresholds.

Results from the PHOSP-R* trial show that exercise-based rehabilitation (EBR) improves short-term exercise capacity in individuals with post-COVID syndrome (long COVID) following an acute hospitalization.

Disease burden has significantly increased because of the COVID-19 pandemic, particularly mental health disorders, malaria in young children in the African region, and stroke and ischaemic heart disease in older adults, reports a study.